TruBridge, Inc. (TBRG) Company Overview

TruBridge provides healthcare technology and services to rural and community hospitals, clinics, and smaller medical groups. Its platform combines revenue cycle management, coding, analytics, managed IT, patient engagement, and electronic health records. TBRG traded on Nasdaq until July 9, 2026, when IKS Health completed the acquisition and TruBridge became a wholly owned subsidiary.

Two segments, one rural-care focus

The former public company reported two segments. Financial Health offered RCM, billing, coding, consulting, managed IT, analytics, and EHR-agnostic software. Patient Care supplied acute-care EHR, implementation, cloud delivery, support, and patient-engagement tools. The FY2025 Form 10-K defines the core market as U.S. community hospitals with fewer than 400 beds; about 98% of Patient Care hospital customers had fewer than 100 beds.

Customer and geographic profile

TruBridge specialized in providers that cannot spread billing, compliance, cybersecurity, and software costs across a large system. Its U.S.-focused customer base was supported by a growing global workforce, including more than 1,800 employees in India at December 31, 2025. The current company profile and history retains that rural-care identity within IKS Health.

TruBridge earned recurring service fees, SaaS subscriptions, transaction and support revenue, managed-services fees, and implementation revenue. In FY2025, recurring revenue was $327.2 million, or 94.3% of total revenue. Retention, bookings conversion, and labor productivity determined whether that stability produced growth and margin expansion.

Financial Health: recurring RCM plus cross-sell economics

Financial Health was the larger revenue engine and primary growth vehicle. Its EHR-agnostic RCM offering widened the market beyond TruBridge software users, while the Patient Care installed base supplied cross-sell opportunities. Economics depended on improving client collections while standardizing work, automating tasks, and shifting appropriate activity to lower-cost delivery teams.

Patient Care: EHR relationships became subscription relationships

Patient Care moved from license-heavy sales toward subscriptions. SaaS accounted for 100% of new acute-care installations from 2022 through 2025. The shift reduced upfront revenue but increased recurring monthly fees and made bookings, go-live timing, retention, and subscription starts more important.

The final public quarter ended March 31, 2026. The Q1 2026 earnings release reported $86.3 million of revenue, $17.7 million of ACV bookings, $16.5 million of adjusted EBITDA, $0.5 million of GAAP net income, and a 94% recurring-revenue mix.

Q1 2026: stable recurring revenue, weaker GAAP operating margin

Financial Health revenue was $53.3 million, while Patient Care revenue was $33.0 million. Operating income was $3.1 million, a 3.5% margin. Financial Health adjusted EBITDA was $7.7 million and Patient Care adjusted EBITDA was $8.8 million, showing that stronger Patient Care profitability partly offset pressure in the larger RCM segment.

FY2025: modest growth with a substantial profitability recovery

FY2025 revenue was $346.8 million, operating income was $20.8 million, net income was $4.4 million, and adjusted EBITDA was $68.7 million. Global delivery, cost actions, and stronger Patient Care economics helped, although amortization, interest, and restructuring kept GAAP conversion modest.

TruBridge evolved from hospital information systems into recurring RCM, SaaS, analytics, and outsourced operations. Its official history shows how acquisitions, divestitures, and the 2024 rebrand changed the revenue mix and strategic focus.

1. 1979
   CPSI founded, establishing rural-hospital domain expertise and an installed base.
2. 2013
   TruBridge services brand launched, adding recurring outsourcing and consulting.
3. 2016
   Healthland acquired, expanding rural reach but increasing portfolio complexity.
4. 2019–2022
   Get Real Health, TruCode, and Healthcare Resource Group broadened engagement, coding, and RCM.
5. 2023
   Viewgol added ambulatory analytics and a scaled India delivery operation.
6. 2024
   Post-acute assets were sold and CPSI became TruBridge, concentrating on Financial Health and Patient Care.
7. 2026
   IKS Health acquired TruBridge, ending the listing and moving the platform into a larger care-enablement group.

The trade-off was acquisition breadth versus financial complexity. At year-end 2025, TruBridge carried $172.6 million of goodwill, along with substantial intangible assets, debt, and integration obligations. Cross-sell potential improved, but cash conversion and control quality became more important.

TruBridge lacked the scale of Epic, Oracle Health, or Meditech. Its defense was specialization: products, implementation, financing, and support designed for resource-constrained hospitals. Decades of rural-health experience and the ability to bundle EHR with RCM created relationship depth that a generalist entrant would need time to reproduce.

Switching costs and workflow integration

EHR replacement disrupts clinical documentation, billing, interfaces, training, and historical records; RCM outsourcing embeds the vendor in daily collections. These switching costs support retention and cross-sell, but hospitals can still consolidate, close, migrate, or demand concessions. The moat was workflow- and relationship-based, not a technological monopoly.

Global delivery and analytics as cost advantages

Viewgol added ambulatory analytics and a large India workforce. In FY2025, lower domestic labor costs and global delivery contributed to a $2.8 million reduction in Financial Health cost of revenue. That matters in labor-intensive RCM, where automation and standardized workflows can expand margins. The closing announcement says the combined organization supports more than 2,000 healthcare organizations and 150,000 clinicians.

Financial strength was mixed: recurring revenue and adjusted EBITDA supported cash generation, but debt, amortization, restructuring, and software investment constrained GAAP earnings. At March 31, 2026, TruBridge held $35.4 million of cash and $163.9 million of debt, or about $128.4 million of net debt.

Cash conversion improved before the take-private

After capitalized software and PP&E investment, an analytical free-cash-flow proxy was about $11.7 million in Q1 2026 and $19.8 million for FY2025. These are not company-defined measures, but they show why capitalized development and working-capital movements must be reconciled to operating cash flow.

Accounting quality was a material constraint

The FY2025 filing was delayed by errors involving revenue recognition, contract costs, compensation, and capitalized software. Management reported material weaknesses in the revenue cycle, software capitalization, and non-routine transactions. These controls affect growth, margins, and asset values. The Q1 2026 Form 10-Q provides the final public balance sheet and cash-flow update.

Patient Care faced larger EHR vendors with broader footprints and development budgets. Financial Health competed with transaction platforms, software vendors, and RCM outsourcers. TruBridge defended itself through rural-market fit, service intensity, and connected clinical and financial workflows rather than lowest price or widest functionality.

Market position depended on retention and cross-sell

Patient Care supplied durable EHR relationships and a cross-sell population; Financial Health offered the higher-growth route and addressed urgent cash-collection needs. Weak EHR retention would shrink the pool, while poor RCM execution could damage the broader account. Bookings and retention therefore belonged in the same analysis.

Before closing, TruBridge had one common share class and a concentrated register. The 2025 Form 10-K/A ownership table, dated April 24, 2026, listed Pinetree Capital at 19.9%, Ocho Investments at 7.4%, Gran Fondo Capital at 6.3%, and directors and executives as a group at 11.4%. The executive-group figure included overlap with Ocho-related director Andris Upitis.

The strategic review ended public ownership

The strategic review produced an April 23, 2026 merger agreement. Stockholders approved it, and on July 9 each eligible share converted into $26.25 cash. The definitive merger proxy details the process and terms. TBRG then ceased trading.

Why the ownership change matters

Private ownership may support longer-horizon automation and integration while eliminating public-company costs. It also reduces standalone disclosure. Research now centers on strategic fit, integration, client retention, and parent-level capital allocation rather than quarterly TBRG guidance.

The main opportunity is combining TruBridge's rural-hospital relationships, EHR, coding, and RCM with IKS Health's larger platform. The closing release cites a $260 billion combined addressable market, but that is strategic framing, not a revenue forecast. Value requires cross-sell, automation, fast integration, and measurable client outcomes.

Operating metrics that reveal execution

Risks are concentrated in execution, customers, regulation, and controls

Rural hospitals face thin margins, staffing shortages, reimbursement volatility, and closure risk. Those conditions create demand but can delay projects or eliminate customers. TruBridge also handles protected health information and mission-critical workflows, making cybersecurity and privacy material. Larger EHR and RCM competitors have greater resources, while unresolved accounting controls can distort contract, revenue, and software-development reporting.

A standalone DCF is now historical because TBRG no longer trades. The case remains useful: recurring revenue, slow growth, restructuring, capitalized software, debt, and acquisition accounting created a wide gap between adjusted EBITDA, GAAP earnings, and cash flow.

The merger price is an observed outcome, not proof of intrinsic value

The $26.25 consideration was a negotiated control transaction shaped by synergies, financing, and a specific market date—not a universal multiple. A pre-merger analysis would compare it with standalone free cash flow, net debt, segment quality, and durable cost savings. IKS must instead test whether cross-sell and lower unit costs justify purchase and integration risk.

TruBridge was a specialized healthcare workflow company for smaller providers. The EHR created long-lived relationships; RCM, coding, analytics, and managed services expanded monetization. FY2025 revenue was 94.3% recurring and adjusted EBITDA reached $68.7 million, but GAAP net income was only $4.4 million, leverage remained meaningful, and control weaknesses complicated interpretation.

Monitor recurring revenue dollars, ACV bookings, EHR retention, segment EBITDA, cash flow after capitalized software, client continuity, and IKS integration. Those variables now matter more than the former ticker price.